
Long-term outcomes of GD2-directed CAR-T cell therapy in patients with neuroblastoma
The development of chimeric antigen receptor (CAR)-T cell therapy has revolutionized cancer treatment, particularly for hematologic malignancies. However, its long-term efficacy in solid tumors, such […]